PRKAA2 and obesity due to melanocortin 4 receptor deficiency: In light of these findings and the current lack of comprehensive in vivo studies, our research investigates the hypothesis that RJ administration can alleviate obesity in high-fat diet (HFD)-fed rats by inhibiting adipogenesis and promoting lipolysis and fatty acid oxidation, primarily through AMPK activation.